Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 297,200 | 245,316 | 205,622 | 198,871 | 212,174 |
| Cost of Goods | 35,399 | 25,212 | 17,562 | 21,142 | 23,539 |
| Gross Profit | 261,801 | 220,104 | 188,060 | 177,729 | 188,635 |
| Operating Expenses | 270,821 | 225,703 | 170,389 | 164,310 | 112,918 |
| Operating Income | -8,621 | -5,387 | 18,233 | 13,561 | 76,256 |
| Other Income | 129 | -6,625 | -3,246 | 9,517 | -32,162 |
| Pre-tax Income | -8,492 | -12,012 | 14,987 | 23,078 | 44,094 |
| Income Tax | 3,349 | -1,464 | 1,313 | 7,082 | 6,348 |
| Net Income Continuous | -11,841 | -10,548 | 13,674 | 15,996 | 37,746 |
| Net Income | $-11,841 | $-10,548 | $13,674 | $15,996 | $37,746 |
| EPS Basic Total Ops | -0.18 | -0.16 | 0.21 | 0.25 | 0.58 |
| EPS Basic Continuous Ops | -0.18 | -0.16 | 0.21 | 0.25 | 0.59 |
| EPS Diluted Total Ops | -0.18 | -0.16 | 0.19 | 0.23 | 0.55 |
| EPS Diluted Continuous Ops | -0.15 | -0.15 | 0.19 | 0.23 | 0.55 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.14 | 0.03 | 0.19 | 0.58 |
| EBITDA(a) | $7,449 | $10,538 | $31,421 | $33,171 | $84,570 |